These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 31733218)

  • 1. Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms.
    Kato T; Duman RS
    Pharmacol Biochem Behav; 2020 Jan; 188():172827. PubMed ID: 31733218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapastinel, an NMDAR positive modulator, produces distinct behavioral, sleep, and EEG profiles compared with ketamine.
    Banerjee P; Donello JE; Hare B; Duman RS
    Behav Brain Res; 2020 Aug; 391():112706. PubMed ID: 32461133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
    Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-Like Effects.
    Donello JE; Banerjee P; Li YX; Guo YX; Yoshitake T; Zhang XL; Miry O; Kehr J; Stanton PK; Gross AL; Burgdorf JS; Kroes RA; Moskal JR
    Int J Neuropsychopharmacol; 2019 Mar; 22(3):247-259. PubMed ID: 30544218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.
    Newport DJ; Carpenter LL; McDonald WM; Potash JB; Tohen M; Nemeroff CB;
    Am J Psychiatry; 2015 Oct; 172(10):950-66. PubMed ID: 26423481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants.
    Wang YT; Zhang NN; Liu LJ; Jiang H; Hu D; Wang ZZ; Chen NH; Zhang Y
    Biochem Biophys Res Commun; 2022 Feb; 594():46-56. PubMed ID: 35074585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of mTOR1 signaling in the antidepressant effects of ketamine and the potential of mTORC1 activators as novel antidepressants.
    Kato T
    Neuropharmacology; 2023 Feb; 223():109325. PubMed ID: 36334763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the antidepressant effect of ketamine separate from its psychotomimetic effect? A review of rodent models.
    Acero-Castillo MC; Correia MBM; Caixeta FV; Motta V; Barros M; Maior RS
    Neuropharmacology; 2024 Nov; 258():110088. PubMed ID: 39032814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine and the potential role for rapid-acting antidepressant medications.
    Krystal JH
    Swiss Med Wkly; 2007 Apr; 137(15-16):215-6. PubMed ID: 17525875
    [No Abstract]   [Full Text] [Related]  

  • 10. N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice.
    Lin JC; Chan MH; Lee MY; Chen YC; Chen HH
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():7-13. PubMed ID: 27296677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF release and signaling are required for the antidepressant actions of GLYX-13.
    Kato T; Fogaça MV; Deyama S; Li XY; Fukumoto K; Duman RS
    Mol Psychiatry; 2018 Oct; 23(10):2007-2017. PubMed ID: 29203848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-type specific modulation of NMDA receptors triggers antidepressant actions.
    Pothula S; Kato T; Liu RJ; Wu M; Gerhard D; Shinohara R; Sliby AN; Chowdhury GMI; Behar KL; Sanacora G; Banerjee P; Duman RS
    Mol Psychiatry; 2021 Sep; 26(9):5097-5111. PubMed ID: 32488125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant.
    Moskal JR; Burgdorf JS; Stanton PK; Kroes RA; Disterhoft JF; Burch RM; Khan MA
    Curr Neuropharmacol; 2017; 15(1):47-56. PubMed ID: 26997507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine.
    Zanos P; Brown KA; Georgiou P; Yuan P; Zarate CA; Thompson SM; Gould TD
    J Neurosci; 2023 Feb; 43(6):1038-1050. PubMed ID: 36596696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.
    Hashimoto K
    Psychiatry Clin Neurosci; 2019 Oct; 73(10):613-627. PubMed ID: 31215725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive
    Witkin JM; Mitchell SN; Wafford KA; Carter G; Gilmour G; Li J; Eastwood BJ; Overshiner C; Li X; Rorick-Kehn L; Rasmussen K; Anderson WH; Nikolayev A; Tolstikov VV; Kuo MS; Catlow JT; Li R; Smith SC; Mitch CH; Ornstein PL; Swanson S; Monn JA
    J Pharmacol Exp Ther; 2017 Apr; 361(1):68-86. PubMed ID: 28138040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of ketamine and its metabolites as antidepressants.
    Hess EM; Riggs LM; Michaelides M; Gould TD
    Biochem Pharmacol; 2022 Mar; 197():114892. PubMed ID: 34968492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine.
    Hashimoto K
    Biochem Pharmacol; 2020 Jul; 177():113935. PubMed ID: 32224141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking NMDA receptor at rest: a possible alleviation of depression.
    Lu W
    Acta Pharmacol Sin; 2011 Sep; 32(9):1087-8. PubMed ID: 21804573
    [No Abstract]   [Full Text] [Related]  

  • 20. The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus.
    Burgdorf J; Zhang XL; Weiss C; Gross A; Boikess SR; Kroes RA; Khan MA; Burch RM; Rex CS; Disterhoft JF; Stanton PK; Moskal JR
    Neuroscience; 2015 Nov; 308():202-11. PubMed ID: 26343295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.